Early initiation of antibiotic therapy and short-term outcomes in preterm infants: a single-centre retrospective cohort analysis

Arch Dis Child Fetal Neonatal Ed. 2023 Nov;108(6):623-630. doi: 10.1136/archdischild-2022-325113. Epub 2023 May 3.

Abstract

Background: Sepsis is one of the most important complications in preterm infants. For this reason, many such infants receive antibiotics during their hospital stay. However, early antibiotic therapy has also been associated with adverse outcome. It is yet largely unclear if the time of onset of antibiotic therapy influences the outcome. We here investigated whether the timing of initiation of antibiotic therapy plays a role in the association between antibiotic exposure and short-term outcome.

Methods: Retrospective analysis of data from 1762 very low birthweight infants born in a German neonatal intensive care unit (NICU) between January 2004 and December 2021.

Results: Antibiotics were administered to 1214 of the 1762 (68.9%) infants. In 973 (55.2%) of the 1762 of infants, antibiotic therapy was initiated within the first two postnatal days. Only 548 (31.1%) infants did not have any antibiotic prescription during their stay in the NICU. Antibiotic exposure at every timepoint was associated with an increased risk of all short-term outcomes analysed in univariable analyses. In multivariable analyses, initiation of antibiotic therapy within the first two postnatal days and initiation between postnatal days 3 and 6 was independently associated with an increased risk of developing bronchopulmonary dysplasia (BPD) (OR 3.1 and 2.8), while later initiation of antibiotic therapy was not.

Conclusion: Very early initiation of antibiotic therapy was associated with an increased risk of BPD. Due to the study design, no conclusions on causality can be drawn. If confirmed, our data suggest that an improved identification of infants at low risk of early-onset sepsis is needed to reduce antibiotic exposure.

Keywords: Epidemiology; Infectious Disease Medicine; Intensive Care Units, Neonatal; Neonatology; Sepsis.

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Bronchopulmonary Dysplasia* / etiology
  • Cohort Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Retrospective Studies
  • Sepsis* / drug therapy
  • Sepsis* / epidemiology

Substances

  • Anti-Bacterial Agents